EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 365 filers reported holding EXELIXIS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,342 | +94.9% | 2,304 | +70.4% | 0.00% | +100.0% |
| Q2 2023 | $25,836 | +47.1% | 1,352 | +49.4% | 0.00% | +100.0% |
| Q1 2023 | $17,566 | +27.1% | 905 | +5.0% | 0.00% | 0.0% |
| Q4 2022 | $13,826 | +38.3% | 862 | +36.6% | 0.00% | 0.0% |
| Q3 2022 | $10,000 | -65.5% | 631 | -54.3% | 0.00% | -50.0% |
| Q2 2022 | $29,000 | -6.5% | 1,382 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $31,000 | +14.8% | 1,359 | -7.9% | 0.00% | 0.0% |
| Q4 2021 | $27,000 | +8.0% | 1,476 | +22.4% | 0.00% | 0.0% |
| Q3 2021 | $25,000 | +177.8% | 1,206 | +134.6% | 0.00% | +100.0% |
| Q2 2021 | $9,000 | -25.0% | 514 | -3.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | -20.0% | 530 | -30.9% | 0.00% | 0.0% |
| Q4 2020 | $15,000 | -25.0% | 767 | -5.9% | 0.00% | -50.0% |
| Q3 2020 | $20,000 | +11.1% | 815 | +5.0% | 0.00% | 0.0% |
| Q2 2020 | $18,000 | +50.0% | 776 | +7.6% | 0.00% | +100.0% |
| Q1 2020 | $12,000 | -80.0% | 721 | -78.8% | 0.00% | -83.3% |
| Q4 2019 | $60,000 | +275.0% | 3,396 | +281.1% | 0.01% | +50.0% |
| Q3 2019 | $16,000 | -80.7% | 891 | -77.2% | 0.00% | -50.0% |
| Q2 2019 | $83,000 | -6.7% | 3,907 | +3.5% | 0.01% | -11.1% |
| Q1 2019 | $89,000 | +20.3% | 3,776 | -0.3% | 0.01% | 0.0% |
| Q4 2018 | $74,000 | +722.2% | 3,789 | +657.8% | 0.01% | +200.0% |
| Q3 2018 | $9,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |